康注射与化疗相结合对晚期非小细胞肺癌免疫功能的影响:元分析
Yaoyao Wang1, Xiaomei Wang1, Hongnian Zhang2
1Henan University of Chinese Medicine, Zhengzhou, Henan, China.
Frontiers in pharmacology
|February 9, 2026
概括
康康康康康,就是这样一个人.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 晚期非小细胞肺癌 (NSCLC) 存在重大治疗挑战.
- 基于的化疗是一种标准治疗方法,但疗效和毒性仍然令人担忧.
- 研究辅助疗法以改善结果至关重要.
研究的目的:
- 系统地评估与基化疗相结合的康注射 (KAI).
- 评估对晚期NSCLC患者免疫功能,临床疗效和安全性的影响.
主要方法:
- 在2025年9月之前,对中国和英语数据库进行系统的文献搜索.
- 包括随机对照试验 (RCT),比较KAI加化疗与单独化疗.
- 使用RevMan 5.3和Stata 18.0进行的元分析,通过GRADE进行质量评估.
主要成果:
- 分析了14个涉及1214名患者的RCT.
- 组合疗法显著改善了客观反应率和增强的免疫参数 (CD3 +,CD4 +,CD4 +/CD8 +比率,NK细胞).
- 观察到瘤标志物,VEGF水平以及与化疗相关的不良事件 (白血病,恶心,吐) 的减少.
结论:
- 康注射作为辅助疗法可以增强高级NSCLC的免疫功能.
- KAI提高了化疗反应率,并减轻了治疗毒性.
- 提供了关于高级NSCLC综合临床管理的证据.
相关概念视频
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...